Effects of gliclazide add on metformin on serum omentin-1 levels in patients with type 2 diabetes mellitus
Background: Omentin is a newly identified adipokine that has beneficial influence against cardiovascular disorders. Hence, considering the impact of anti-diabetic drug on omentin levels may provide an adjuvant strategy to protect diabetic patients against valuable clinical hazards. Aim of the Study:...
Uloženo v:
| Hlavní autoři: | , , |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Wolters Kluwer Medknow Publications
2016-01-01
|
| Edice: | Indian Journal of Endocrinology and Metabolism |
| Témata: | |
| On-line přístup: | http://www.ijem.in/article.asp?issn=2230-8210;year=2016;volume=20;issue=2;spage=195;epage=198;aulast=Al-Gareeb |
| Tagy: |
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
|